TuHURA Biosciences files IND for TBS-2025 antibody in blood cancers
TuHURA Biosciences Inc. (NASDAQ: HURA) filed an Investigational New Drug application with the U.S. Food and Drug Administration for its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
